Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.

about

Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.

Item

http://www.wikidata.org/entity/Q38705266

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Extended infusion of beta-lact ...... a of antimicrobial resistance.

@en

type

Item

label

Extended infusion of beta-lact ...... a of antimicrobial resistance.

@en

prefLabel

Extended infusion of beta-lact ...... a of antimicrobial resistance.

@en

P1476

Extended infusion of beta-lact ...... ra of antimicrobial resistance

@en

P2093

Hussam Z Tabaja

http://www.w3.org/2001/XMLSchema#string

Zeina A Kanafani

http://www.w3.org/2001/XMLSchema#string

P2860

Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa

What's new in multidrug-resistant pathogens in the ICU?

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.

Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.

The structure of beta-lactamases.

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic.

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.

P304

645-652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14787210.2017.1348894

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nesrine Rizk

S S Kanj

P577

2017-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28657373

http://www.w3.org/2001/XMLSchema#string